Results 131 to 140 of about 5,788 (178)

Activated Sludge in the Bioremediation of Water Containing SARS-CoV-2 Antivirals. [PDF]

J Xenobiot
Lastovčić D, Zirn I, Jezerčić T, Bule Možar K, Večenaj L, Cvetnić M, Ujević Bošnjak M, Markić M, Bolanča T, Ukić Š, Kučić Grgić D.   +10 more
europepmc   +1 more source

Impact of Resistance Associated Substitutions and Predictors of Treatment Failure Following Direct-acting Antiviral Therapy in a Viral Hepatitis C Elimination Cohort. [PDF]

J Clin Exp Hepatol
Premkumar M, Gupta E, Sandhu A, Sharma P, Nain J, Taneja S, Verma N, De A, Duseja A, Grover GS, Dhiman RK.   +10 more
europepmc   +1 more source

Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study. [PDF]

BMJ Open
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Gholamreza Shirazi P.   +5 more
europepmc   +1 more source

Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature. [PDF]

Cureus
Malakar S, Kumar S, Jangra R, Agarwal M, Parwar A, Kohli KP, Mishra S, Bhardwaj A, Kumar A, Singh A, Yadav DK, Tiwari A, Gandhi A, Shukla G, Rungta S.   +14 more
europepmc   +1 more source

Machine learning-based prediction of treatment response in comorbid hepatitis C patients receiving DAA therapy: a real-world study from Pakistan. [PDF]

Front Public Health
Nishwa DE, Abbas Z, Lee SW.
europepmc   +1 more source

Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial. [PDF]

EClinicalMedicine
Turner HC, Ahmed S, Nguyen HA, Hung LM, Van Nuil J, Thuan DT, SEARCH investigators, Dung NT, Thwaites GE, Walker AS, Chau NVV, Cooke GS, Hallett TB.   +12 more
europepmc   +1 more source

Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. [PDF]

J Viral Hepat
Luong CL, Ellett LK, Pratt N, Staff K, Janetzki J.   +4 more
europepmc   +1 more source

Prevalence of Y93H resistance-associated substitution in treatment-naïve hepatitis C virus genotype 1b patients: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Kakru DK, Lee DY, Kumar N, Arcot R, Lakhanpal S, Das S, Kumar S, Katkuri SN, Paul JR, Gaidhane AM, Satapathy P.   +10 more
europepmc   +1 more source

Enhanced information cross-attention fusion for drug-target binding affinity prediction. [PDF]

PeerJ Comput Sci
Fei A, Wang Y, Ruan T, Zhang Y, Yao M, Wang L.   +5 more
europepmc   +1 more source

A novel model of care; Telemedicine and peer support for HCV care among HIV-infected people who inject drugs in remote Myanmar: a retrospective study. [PDF]

Harm Reduct J
Tun NN, Smithuis F, Tun NL, Hteik MMM, Lynen L, Conlon CP, Gils T, van Olmen J, Decroo T.   +8 more
europepmc   +1 more source